Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Graft-versus-host disease.

W F Cassano1

  • 1Department of Pediatrics, University of Florida College of Medicine, Gainesville.

The Journal of the Florida Medical Association
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Graft-versus-host disease is a serious complication following bone marrow transplants, where donor T lymphocytes attack the recipient. This review covers its diagnosis, grading, and management strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy for childhood acute lymphoblastic leukemia.

Current opinion in oncology·1993
Same author

Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.

Cancer·1991
Same author

Mesenchymal specificity of three new monoclonal antibodies generated to the osteosarcoma cell line 4444T.

Clinical immunology and immunopathology·1991
Same author

Alternative method of gestational age assessment by the measurement of human erythrocyte differentiation antigen expression.

Journal of perinatology : official journal of the California Perinatal Association·1991
Same author

Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation.

Bone marrow transplantation·1991
Same author

Characterization of a new T-lineage glycoprotein expressed in mature T-cell leukemias and lymphomas.

Blood·1990
Same journal

The dawning of the age of accountability.

The Journal of the Florida Medical Association·1999
Same journal

Physician office-based quality improvement projects. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
Same journal

Hyperlipidemia management in patients with cardiovascular and cerebrovascular disease.

The Journal of the Florida Medical Association·1998
Same journal

On the horizon: newly-developed quality improvement projects. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
Same journal

Angiotensin converting enzyme inhibitor use in congestive heart failure. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
Same journal

Influenza immunization among Medicare beneficiaries enrolled in a health maintenance organization: 1994. Florida Medical Quality Assurance, Inc.

The Journal of the Florida Medical Association·1998
See all related articles

Area of Science:

  • Immunology
  • Transplantation Medicine

Background:

  • Graft-versus-host disease (GvHD) is a rare but severe complication.
  • It occurs when donor T lymphocytes attack a compromised host.
  • Commonly seen after allogeneic bone marrow transplantation and in certain immunodeficiency disorders.

Purpose of the Study:

  • To review the diagnostic features of GvHD.
  • To outline the clinical grading system for GvHD severity.
  • To discuss current therapeutic and preventive strategies for GvHD.

Main Methods:

  • Literature review of diagnostic criteria.
  • Analysis of clinical grading scales.
  • Synthesis of treatment and prevention protocols.

Main Results:

Related Experiment Videos

  • GvHD presents with characteristic clinical manifestations.
  • Standardized grading systems aid in assessing severity.
  • Various therapeutic and prophylactic measures exist.

Conclusions:

  • Early diagnosis and appropriate management are crucial for GvHD.
  • Understanding GvHD pathogenesis informs prevention and treatment.
  • Continued research is needed to improve outcomes for transplant recipients.